Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based K
V
1.3 Inhibitors and Their Potential for Anticancer Activity.
Cancers
2022,
14
, 2595
Cancers (Basel)
.
2023 May 26;15(11):2925.
doi: 10.3390/cancers15112925.
Authors
Špela Gubič
1
,
Louise Antonia Hendrickx
2
,
Xiaoyi Shi
3
,
Žan Toplak
1
,
Štefan Možina
1
,
Kenny M Van Theemsche
4
5
,
Ernesto Lopes Pinheiro-Junior
2
,
Steve Peigneur
2
,
Alain J Labro
4
5
,
Luis A Pardo
3
,
Jan Tytgat
2
,
Tihomir Tomašič
1
,
Lucija Peterlin Mašič
1
Affiliations
1
Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.
2
Campus Gasthuisberg, University of Leuven, Toxicology and Pharmacology, Onderwijs en Navorsing 2, Herestraat 49, 3000 Leuven, Belgium.
3
AG Oncophysiology, Max-Planck Institute for Multidisciplinary Sciences, Hermann-Rein-Str. 3, 37075 Göttingen, Germany.
4
Laboratory for Molecular, Cellular and Network Excitability, Department of Biomedical Sciences, University of Antwerp, 2610 Wilrijk, Belgium.
5
Department of Basic and Applied Medical Sciences, Ghent University, Corneel Heymanslaan 10 (Entrance 36), 9000 Ghent, Belgium.
PMID:
37297027
PMCID:
PMC10252048
DOI:
10.3390/cancers15112925
Abstract
In the original publication [...].
Publication types
Published Erratum
Grants and funding
J1-9192, N1-0098, P1-0245/Slovenian Research Agency
No. 813834-PHIONIC-H2020-MSCA-ITN-2018./Max Planck Society
GOE7120N, GOC2319N, and GOA4919N/Research Foundation - Flanders
PDM/19/164/KU Leuven
Vlaanderen grant 12W7822N/Research Foundation - Flanders